Board of Directors
Patricia Leuchten
Chair of the Board
Read bio
A pharma industry leader and entrepreneur with a focus on driving improvements in clinical trial execution, at scale, through innovative solutions. In 1999, she founded The Avoca Group, whose Avoca Quality Consortium paved the way for Diligent Pharma and the Diligent Qualification Platform.
Todd Johnson, MBA
Read bio
Partner with FCA Venture Partners. 20+ years as a leader in early-stage healthcare companies, including the founding of HealthTech Corp, where he also served as CEO. Todd later co-founded and was a Managing Partner for KeraNetics.
Coleen Glessner, MBA
Read bio
A pharma industry executive currently serving as Executive Vice President, Enterprise Risk, Regulatory Affairs, Ethics and Compliance and Chief Quality Officer at Emergent Biosolutions with a passion and focus for transformational change through process and culture. Beginning her career in clinical trial operations at Warner Lambert Parke-Davis, Coleen later held senior leadership positions at Alexion and Pfizer. She earned an MBA from Massachusetts Institute of Technology and is passionate about entrepreneurship for women leaders.
David Martirano
Board Observer
Read bio
An investment expert, David is the Managing Partner and a co-founder of PJC, a venture capital firm. With extensive experience investing broadly in B2B SaaS, Consumer and Tech Enabled Service companies, he currently sits on the Board of Trustees at the University of Rhode Island and the Investment Committee of Lifespan.
Tom Hearn, MPH, MBA
Board Observer
Read bio
30+ years as a healthcare leader, with experience serving as Senior Vice President of Ambulatory Services for Novant Health, Inc., Chief Development Officer of MedCath, Inc. and CEO of MedCath Partners, LLC. Tom also co-founded and served as President of Decision Support Systems and was VP of Administration at Atrium Health.